Pécsi Tudományegyetem Klinikai Központ
- Address
- lock Available on a paid plan
Pécsi Tudományegyetem Klinikai Központ - Dermatology Research Center
Pécsi Tudományegyetem Klinikai Központ (University of Pécs Clinical Center) is a distinguished academic medical institution actively engaged in advancing dermatological research, with particular expertise in chronic inflammatory skin conditions. The center participates in international multi-center clinical trials to evaluate innovative therapeutic approaches for patients suffering from severe dermatological diseases.
- Long-term safety and efficacy studies of novel immunomodulatory agents
- Treatment of moderate-to-severe plaque psoriasis
- Extension trials evaluating sustained therapeutic outcomes
The clinical center's research portfolio emphasizes the characterization of long-term safety profiles and tolerability of emerging treatments, specifically investigating BMS-986165 for patients with chronic plaque psoriasis. This commitment to extended observation periods ensures comprehensive understanding of therapeutic benefits and potential risks, contributing valuable real-world evidence to the dermatology community.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 332 other sites in Hungary
Therapeutic Area Benchmark — Hungary
Select a therapeutic area to compare against other sites in Hungary.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Hungary
Market Share
Country: Hungary
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Pécsi Tudományegyetem Klinikai Központ
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| An Open-Label, Multi-Center Extension Study to Characterize the Long-Term Safety and Efficacy of BMS-986165 in Subjects with Moderate-to-Severe Plaque Psoriasis | Bristol-Myers Squibb Services Unlimited Company | Phase III | Not Recruiting | Dec 2019 | Jul 2025 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Deucravacitinib | 1 | Unknown | 2019-12-12 | 2019-12-12 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.